Dy, Grace K.
Nesline, Mary K.
Papanicolau-Sengos, Antonios
DePietro, Paul
LeVea, Charles M.
Early, Amy
Chen, Hongbin
Grand’Maison, Anne
Boland, Patrick
Ernstoff, Marc S.
Edge, Stephen
Akers, Stacey
Opyrchal, Mateusz
Chatta, Gurkamal
Odunsi, Kunle
Pabla, Sarabjot
Conroy, Jeffrey M.
Glenn, Sean T.
DeFedericis, Hanchun T.
Burgher, Blake
Andreas, Jonathan
Giamo, Vincent
Qin, Maochun
Wang, Yirong
Kanehira, Kazunori
Lenzo, Felicia L.
Frederick, Peter
Lele, Shashikant
Galluzzi, Lorenzo
Kuvshinoff, Boris
Morrison, Carl http://orcid.org/0000-0002-3441-8363
Article History
Received: 18 July 2018
Accepted: 10 January 2019
First Online: 18 January 2019
Ethics approval and consent to participate
: OmniSeq’s analysis utilized deidentified data that was considered non-human subjects research under IRB-approved protocol (BDR #073166) at Roswell Park Comprehensive Cancer Center (Buffalo, NY).
: Not applicable
: Disclosures: SP, JMC, MKN, STG, APS, BB, JA, VG, HTD, MQ, YW, FLL, and CM are all employees of OmniSeq, Inc. (Buffalo, NY) and hold restricted stock in OmniSeq, Inc. GD, MLV, AE, HC, AGM, PB, SE, SA, MO, GC, KO, KK, PF, SL, BK, CM, STG, JMC, and MSE are employees of Roswell Park Comprehensive Cancer Center (Buffalo, NY). Roswell Park Comprehensive Cancer Center is the majority shareholder of OmniSeq, Inc. MSE and LG provide remunerated consulting to OmniSeq, Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.